# FDA Inspection 1137255 - Berman, Gary D., MD, Clinical Investigator - March 29, 2021

Source: https://www.keypedia.com/records/fda_inspections/berman-gary-d-md-clinical-investigator/072c9bc0-b1bd-426f-aaaf-324fc2259dbd
Source feed: FDA_Inspections

> FDA Inspection 1137255 for Berman, Gary D., MD, Clinical Investigator on March 29, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1137255
- Company Name: Berman, Gary D., MD, Clinical Investigator
- Inspection Date: 2021-03-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 841024 - 2013-07-29](https://www.keypedia.com/records/fda_inspections/berman-gary-d-md-clinical-investigator/ba3e43bb-b36f-446a-85c9-4f1cb8ebc6b5)

Company: https://www.keypedia.com/companies/berman-gary-d-md-clinical-investigator/f9a75410-4db9-4678-8734-3cf19058822d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d